48 related articles for article (PubMed ID: 31273789)
1. MiR-496 promotes migration and epithelial-mesenchymal transition by targeting RASSF6 in colorectal cancer.
Wang H; Yan B; Zhang P; Liu S; Li Q; Yang J; Yang F; Chen E
J Cell Physiol; 2020 Feb; 235(2):1469-1479. PubMed ID: 31273789
[TBL] [Abstract][Full Text] [Related]
2. DJ-1 promotes epithelial-to-mesenchymal transition via enhancing FGF9 expression in colorectal cancer.
Li L; Zhang C; Li Y; Zhang Y; Lei Y
Biol Open; 2020 May; 9(5):. PubMed ID: 32366371
[TBL] [Abstract][Full Text] [Related]
3. Roles of miR-4442 in Colorectal Cancer: Predicting Early Recurrence and Regulating Epithelial-Mesenchymal Transition.
Shibamoto J; Arita T; Konishi H; Kataoka S; Furuke H; Takaki W; Kiuchi J; Shimizu H; Yamamoto Y; Komatsu S; Shiozaki A; Kuriu Y; Otsuji E
Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510319
[TBL] [Abstract][Full Text] [Related]
4. Comparative Analysis of miRNA and EMT Markers in Metastatic Colorectal Cancer.
Hanusova V; Matouskova P; Manethova M; Soukup J; John S; Zofka M; Vošmikova H; Krbal L; Rudolf E
Cancer Invest; 2023 Dec; 41(10):837-847. PubMed ID: 37997798
[TBL] [Abstract][Full Text] [Related]
5. Alternative splicing of the OCC-1 gene generates three splice variants and a novel exonic microRNA, which regulate the Wnt signaling pathway.
Najafi H; Soltani BM; Dokanehiifard S; Nasiri S; Mowla SJ
RNA; 2017 Jan; 23(1):70-85. PubMed ID: 27986894
[TBL] [Abstract][Full Text] [Related]
6. Construction and Validation of an Immune-Related Prognostic Model Based on TP53 Status in Colorectal Cancer.
Zhao X; Liu J; Liu S; Yang F; Chen E
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31689990
[TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA
Li H; Wang M; Zhou H; Lu S; Zhang B
Cancer Manag Res; 2020; 12():9339-9349. PubMed ID: 33061623
[TBL] [Abstract][Full Text] [Related]
8. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
9. miR-144-3p inhibits cell proliferation of colorectal cancer cells by targeting BCL6 via inhibition of Wnt/β-catenin signaling.
Sun N; Zhang L; Zhang C; Yuan Y
Cell Mol Biol Lett; 2020; 25():19. PubMed ID: 32206063
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Key Signaling Pathways and ncRNAs in Colorectal Cancer.
Lee YJ; Kim WR; Park EG; Lee DH; Kim JM; Shin HJ; Jeong HS; Roh HY; Kim HS
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674135
[TBL] [Abstract][Full Text] [Related]
11. Novel insights on perils and promises of miRNA in understanding colon cancer metastasis and progression.
Tariq L; Arafah A; Sehar N; Ali A; Khan A; Rasool I; Rashid SM; Ahmad SB; Beigh S; Dar TUH; Rehman MU
Med Oncol; 2023 Aug; 40(10):282. PubMed ID: 37639075
[TBL] [Abstract][Full Text] [Related]
12. Recent advances microRNAs and metabolic reprogramming in colorectal cancer research.
Xiong B; Huang Q; Zheng H; Lin S; Xu J
Front Oncol; 2023; 13():1165862. PubMed ID: 37576895
[TBL] [Abstract][Full Text] [Related]
13. Oral Spirochete
Aravindraja C; Jeepipalli S; Vekariya KM; Botello-Escalante R; Chan EKL; Kesavalu L
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569480
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the diagnostic and therapeutic roles of microRNAs in colorectal cancer progression and metastasis.
Liang C; Yang JB; Lin XY; Xie BL; Xu YX; Lin S; Xu TW
Front Oncol; 2022; 12():911856. PubMed ID: 36313731
[TBL] [Abstract][Full Text] [Related]
15. Regulation of RASSF by non-coding RNAs in different cancers: RASSFs as masterminds of their own destiny as tumor suppressors and oncogenes.
Farooqi AA; Kapanova G; Kussainov AZ; Datkhayeva Z; Raganina K; Sadykov BN
Noncoding RNA Res; 2022 Jun; 7(2):123-131. PubMed ID: 35702574
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs Are Key Molecules Involved in the Gene Regulation Network of Colorectal Cancer.
Yang F; Xuan G; Chen Y; Cao L; Zhao M; Wang C; Chen E
Front Cell Dev Biol; 2022; 10():828128. PubMed ID: 35465317
[TBL] [Abstract][Full Text] [Related]
17. DLK2 Acts as a Potential Prognostic Biomarker for Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis.
Lee MG; Lee YK; Huang SC; Chang CL; Ko CY; Lee WC; Chen TY; Tzou SJ; Huang CY; Tai MH; Lin YW; Kung ML; Tsai MC; Chen YL; Chang YC; Wen ZH; Huang CC; Chu TH
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456435
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs in Epithelial-Mesenchymal Transition Process of Cancer: Potential Targets for Chemotherapy.
Peng F; Fan H; Li S; Peng C; Pan X
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299149
[TBL] [Abstract][Full Text] [Related]
19. Serum long non‑coding RNA NNT‑AS1 protected by exosome is a potential biomarker and functions as an oncogene via the miR‑496/RAP2C axis in colorectal cancer.
Yin H; Hu J; Ye Z; Chen S; Chen Y
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34132374
[TBL] [Abstract][Full Text] [Related]
20. MiR-145 suppresses the motility of prostate cancer cells by targeting cadherin-2.
Zeng H; Huang Y; Liu Q; Liu H; Long T; Zhu C; Wu X
Mol Cell Biochem; 2021 Oct; 476(10):3635-3646. PubMed ID: 34043125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
